BioSpace News Archive

Edesa Biotech, Inc. today reported financial results for the fiscal year ended September 30, 2021 and provided an update on its business.

According to Emergen Research, the global ultrasound-guided regional anesthesia market size was USD 241.9 Million in 2020 and is expected to reach USD 420.2 Million in 2028 and register a revenue CAGR of 7.1% during the forecast period, 2021-2028.

Therapeutic Solutions International announced today receipt of a Notice of Allowance from the United States Patent and Trademark Office regarding its patent application entitled “Nutraceuticals for Suppressing Indolamine 2,3 Deoxygenase.”

The idea of eliminating cancer cells by exploiting immune system as a treatment modality has come a long way.

RxSight, Inc. today announced plans to participate in the upcoming virtual J.P. Morgan Healthcare Conference. RxSight® management is scheduled to present Thursday, January 13, 2022, at 6:45am PT / 9:45am ET.

23andMe Holding Co., a leading consumer genetics and research company, announced the results of the completed redemption of all of its outstanding warrants to purchase shares of Class A common stock of 23andMe that were issued under the Warrant Agreement, dated October 1, 2020, by and between 23andMe and Continental Stock Transfer & Trust Company, as warrant agent.

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that its management will participate in the 24th Annual Needham Virtual Growth Conference on Tuesday, January 11, 2022.

According to Emergen Research, the global laboratory informatics market size was USD 2.54 billion in 2020 and is expected to reach USD 4.21 billion in 2028 and register a revenue CAGR of 6.5% during the forecast period, 2021-2028.

According to Emergen Research, the global robotics surgical simulation systems market size was USD 476.8 Million in 2020 and is expected to reach USD 1.69 Billion in 2028 and register a revenue CAGR of 17.0% during the forecast period, 2021-2028.

DiRx, today announced that it has successfully raised a total of $10 million in Series A funding, updating its previous announcement of having initially raised $5.75 million in September 2021 during the first phase of the round.